Dr. Christopher Evans, DO

NPI: 1063401263
Total Payments
$1,825
2024 Payments
$753.42
Companies
29
Transactions
77
Medicare Patients
867
Medicare Billing
$91,417

Payment Breakdown by Category

Food & Beverage$1,574 (86.2%)
Gifts$126.63 (6.9%)
Travel$124.66 (6.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,574 74 86.2%
Gift $126.63 2 6.9%
Travel and Lodging $124.66 1 6.8%

Top Paying Companies

Company Total Records Latest Year
Centinel Spine, LLC $229.27 2 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $181.63 10 $0 (2024)
Braintree Laboratories, Inc. $176.58 4 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $172.85 8 $0 (2024)
Davol Inc. $126.27 2 $0 (2023)
Phathom Pharmaceuticals, Inc. $124.85 5 $0 (2024)
Janssen Biotech, Inc. $110.70 4 $0 (2024)
Ardelyx, Inc. $99.81 4 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $57.16 4 $0 (2024)
Amarin Pharma Inc. $54.05 3 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $753.42 31 Takeda Pharmaceuticals U.S.A., Inc. ($149.97)
2023 $124.33 7 Ironwood Pharmaceuticals, Inc ($29.20)
2021 $356.94 6 Centinel Spine, LLC ($229.27)
2020 $90.96 4 Braintree Laboratories, Inc. ($53.32)
2019 $141.49 9 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($69.46)
2018 $225.46 10 DAVOL INC. ($108.98)
2017 $132.44 10 Takeda Pharmaceuticals America, Inc. ($22.30)

All Payment Transactions

77 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.20 General
Category: Gastroenterology
12/06/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $19.70 General
Category: GASTROENTEROLOGY
12/02/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.84 General
Category: GASTROENTEROLOGY
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.73 General
Category: Gastroenterology
11/08/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $40.32 General
Category: Immunology
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.89 General
Category: Gastroenterology
10/31/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $16.21 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
10/18/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $25.06 General
Category: Immunology
10/07/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $29.40 General
Category: INTERNAL MEDICINE
10/04/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $28.14 General
Category: GASTROENTEROLOGY
09/20/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $14.00 General
Category: GI
09/18/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $25.06 General
Category: CRITICAL CARE
08/05/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $30.29 General
Category: Immunology
06/07/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $29.53 General
Category: GASTROENTEROLOGY
06/03/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $24.76 General
Category: INTERNAL MEDICINE
05/31/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $32.14 General
Category: GASTROENTEROLOGY
05/17/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $26.43 General
Category: INTERNAL MEDICINE
05/14/2024 Braintree Laboratories, Inc. SUFLAVE (Drug) Food and Beverage In-kind items and services $35.92 General
Category: GI COLON PREP
05/03/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $24.39 General
Category: INTERNAL MEDICINE
05/02/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $18.61 General
Category: GASTROENTEROLOGY
04/30/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $15.03 General
Category: Immunology
04/19/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $21.40 General
Category: INTERNAL MEDICINE
04/15/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Food and Beverage In-kind items and services $21.51 General
Category: Gastroenterology
04/02/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $35.28 General
Category: Immunology
03/26/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $23.73 General
Category: INFLAMMATION AND IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 223 228 $71,575 $24,272
2022 7 199 211 $49,565 $21,210
2021 8 202 215 $49,873 $22,025
2020 9 243 249 $93,975 $23,911
Total Patients
867
Total Services
903
Medicare Billing
$91,417
Procedure Codes
33

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 38 38 $20,825 $7,480 35.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 57 57 $18,510 $6,700 36.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 25 25 $4,590 $2,163 47.1%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 11 12 $5,260 $1,923 36.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 31 $3,915 $1,923 49.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 13 13 $11,550 $1,678 14.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 24 24 $5,340 $1,653 31.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 13 15 $1,345 $642.75 47.8%
15853 Removal of sutures or staples Office 2023 13 13 $240.00 $109.46 45.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 57 57 $18,240 $6,719 36.8%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 19 19 $7,600 $3,760 49.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 17 17 $6,970 $2,866 41.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 38 44 $5,280 $2,834 53.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 22 23 $4,140 $2,263 54.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 24 24 $5,040 $1,679 33.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 22 27 $2,295 $1,090 47.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 47 47 $15,040 $5,454 36.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2021 21 21 $8,610 $3,846 44.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 39 47 $5,640 $3,104 55.0%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2021 14 14 $5,740 $2,568 44.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 26 28 $5,040 $2,480 49.2%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 11 11 $3,058 $1,893 61.9%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 22 22 $4,620 $1,671 36.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 22 25 $2,125 $1,009 47.5%
45385 Removal of polyps or growths of large bowel using an endoscope Facility 2020 28 28 $29,200 $5,618 19.2%

About Dr. Christopher Evans, DO

Dr. Christopher Evans, DO is a Surgery healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063401263.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Evans, DO has received a total of $1,825 in payments from pharmaceutical and medical device companies, with $753.42 received in 2024. These payments were reported across 77 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,574).

As a Medicare-enrolled provider, Evans has provided services to 867 Medicare beneficiaries, totaling 903 services with total Medicare billing of $91,417. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.

Practice Information

  • Specialty Surgery
  • Location York, PA
  • Active Since 10/19/2005
  • Last Updated 06/30/2025
  • Taxonomy Code 208600000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1063401263

Products in Payments

  • STALIF M (Device) $229.27
  • XIFAXAN (Drug) $181.63
  • VOQUEZNA (Drug) $124.85
  • VENTRALIGHT (Device) $108.98
  • ENTYVIO (Biological) $103.81
  • IBSRELA (Drug) $99.81
  • DUPIXENT (Biological) $81.00
  • SUTAB (Drug) $73.31
  • TREMFYA (Drug) $65.38
  • Linzess (Drug) $57.16
  • Vascepa (Drug) $54.05
  • SUPREP BOWEL PREP (Drug) $53.32
  • EOHILIA (Drug) $46.16
  • STELARA (Biological) $45.32
  • TRELEGY ELLIPTA (Drug) $39.38
  • ENTRESTO (Drug) $36.13
  • SUFLAVE (Drug) $35.92
  • ZENPEP (Drug) $30.14
  • TERLIVAZ (Drug) $25.06
  • PNEUMOVAX 23 (Biological) $24.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Surgery Doctors in York